AXIM® Biotechnologies Files New U.S. Patent Application for Water-Soluble Cannabinoid Molecules
NEW YORK, April 28, 2020 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC: AXIM) (AXIM Biotech, AXIM or the Company), an international healthcare solutions company targeting oncological and cannabinoid research, announced today that the Company has filed an application with the United States Patent and Trademark Office (USPTO) for a patent on water-soluble cannabinoid molecules.
- NEW YORK, April 28, 2020 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC: AXIM) (AXIM Biotech, AXIM or the Company), an international healthcare solutions company targeting oncological and cannabinoid research, announced today that the Company has filed an application with the United States Patent and Trademark Office (USPTO) for a patent on water-soluble cannabinoid molecules.
- AXIM also found similar reaction pathways for creating multi-cannabinoid molecules, where different cannabinoids are incorporated into one chemical entity.
- First, AXIMs scientists are increasing cannabinoid solubility while maintaining the cannabinoid molecules active functional groups after dissolution so that the molecule acts like it otherwise would.
- Founded in 2014, AXIM Biotechnologies, Inc. (AXIM) is a world leader in the research and development of plant and laboratory-derived cannabinoid and oncological therapeutics.